0 Comentários
0 Compartilhamentos
4KB Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
Asia-Pacific PDX Models Market Accelerates with Rising Oncology Research InvestmentsAccording to the latest report published by Data Bridge Market Research, the Asia-Pacific Patient Derived Xenograft (PDX) Models Market CAGR Value To impart a supreme quality to this persuasive Asia-Pacific Patient Derived Xenograft (PDX) Models Market report, unswerving efforts of enthusiastic, dynamic and skilled researchers and analysts have been utilized. Evaluations...0 Comentários 0 Compartilhamentos 164 Visualizações 0 Anterior
-
Oncology Based In-Vivo Contract Research Organization (CRO) Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033Oncology Based In-Vivo Contract Research Organization (CRO) Market Summary: According to the latest report published by Data Bridge Market Research, the Oncology Based In-Vivo Contract Research Organization (CRO) Market The global oncology based In-Vivo contract research organization (CRO) market size was valued at USD 1.29 billion in 2025 and is expected to reach USD...0 Comentários 0 Compartilhamentos 561 Visualizações 0 Anterior
-
VEGF-B Inhibitors Market Gains Traction with Advances in Cardiovascular and Oncology Research"Executive Summary VEGF-B Inhibitors Market Size, Share, and Competitive Landscape CAGR Value Global VEGF-B inhibitors market size was valued at USD 1.27 Billion in 2024 and is projected to reach USD 3.75 billion by 2032, with a CAGR of 14.4% during the forecast period of 2025 to 2032. An exceptional VEGF-B Inhibitors Market research document can be formulated well with the blend of top...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Why Pharmaceutical Companies Are Expanding Oncology Research PipelinesOncolytic Virus Therapy Market According to the latest report published by Data Bridge Market Research, the Oncolytic Virus Therapy Market The global oncolytic virus therapy market size was valued at USD 1.12 billion in 2025 and is expected to reach USD 5.79 billion by 2033, at a CAGR of 22.80% during the forecast period All the data and...0 Comentários 0 Compartilhamentos 310 Visualizações 0 Anterior
-
Why Pharmaceutical Companies Are Expanding Oncology Research PipelinesOncolytic Virus Therapy Market According to the latest report published by Data Bridge Market Research, the Oncolytic Virus Therapy Market The global oncolytic virus therapy market size was valued at USD 1.12 billion in 2025 and is expected to reach USD 5.79 billion by 2033, at a CAGR of 22.80% during the forecast period All the data and...0 Comentários 0 Compartilhamentos 301 Visualizações 0 Anterior
-
Why Pharmaceutical Companies Are Expanding Oncology Research PipelinesOncolytic Virus Therapy Market According to the latest report published by Data Bridge Market Research, the Oncolytic Virus Therapy Market The global oncolytic virus therapy market size was valued at USD 1.12 billion in 2025 and is expected to reach USD 5.79 billion by 2033, at a CAGR of 22.80% during the forecast period All the data and...0 Comentários 0 Compartilhamentos 259 Visualizações 0 Anterior
-
Carcinoid Syndrome Drug Market Gains Momentum with Advancements in Targeted TherapiesAccording to the latest report published by Data Bridge Market Research, the Carcinoid Syndrome Drug Market CAGR Value This Carcinoid Syndrome Drug Market research report is a resource, which offers current as well as upcoming technical and financial details of the Carcinoid Syndrome Drug Market industry for the specific forecast period. The report exhibits important product...0 Comentários 0 Compartilhamentos 644 Visualizações 0 Anterior
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Comentários 0 Compartilhamentos 6KB Visualizações 0 Anterior
-
Clinical Oncology Next Generation Sequencing Market Market Size, Top Industry Players and Forecast to 2033Clinical Oncology Next Generation Sequencing Industry Outlook: Straits Research has added a report titled “Global Clinical Oncology Next Generation Sequencing Market Professional Report 2025-2033” to its database of research reports. The study provides complete details about the usage and adoption of Clinical Oncology Next Generation Sequencing in various industrial applications...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Clinical Trials Site Market Developments Across Healthcare Research NetworksThe global clinical trials site market size was valued at USD 6.72 billion in 2024 and is projected to grow from USD 7.14 billion in 2025 to USD 11.57 billion by 2033 at a CAGR of 6.22% during the forecast period (2025-2033). Key Highlights North America dominated the global clinical trials site market. Asia-Pacific is expected to be the fastest-growing region during the forecast...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
-
Emerging Trends Influencing the Antibody Drug Conjugates MarketAsia-Pacific is expected to witness rapid growth in the coming years due to increasing healthcare investments and expanding pharmaceutical manufacturing capabilities. Countries like China and India are emerging as important research hubs. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023,...0 Comentários 0 Compartilhamentos 9KB Visualizações 0 Anterior
-
Future Market Potential of Chemotherapy-Induced Peripheral Neuropathy TreatmentsThe global chemotherapy-induced peripheral neuropathy market size is projected to grow from US$ 1.01 billion in 2025 to approximately US$ 1.67 billion by 2034, reflecting a steady expansion. The market is anticipated to register a compound annual growth rate (CAGR) of around 5.71% during the forecast period, highlighting increasing investments in oncology supportive care. The...0 Comentários 0 Compartilhamentos 8KB Visualizações 0 Anterior
-
Global CAR-T Cell Therapy Market Growth at 17.5% CAGR Through 2030Increasing research and development activities in cell-based therapies are supporting the expansion of the CAR-T cell therapy market. Pharmaceutical and biotechnology companies are investing heavily in clinical trials and advanced technologies. These efforts are accelerating the development of new and effective cancer treatments. CAR-T Cell Therapy Market to Reach US$ 10.13 Billion by 2030...0 Comentários 0 Compartilhamentos 8KB Visualizações 0 Anterior
-
How Cancer Treatment Demand Is Expanding the Asia-Pacific Taxane MarketExecutive Summary Asia-Pacific Taxane Market Size and Share: Global Industry Snapshot CAGR Value Asia-Pacific taxane market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.7% in the forecast period of 2022 to 2029. The research and analysis carried out in this Asia-Pacific...0 Comentários 0 Compartilhamentos 4KB Visualizações 0 Anterior
-
How the Prostate Cancer Diagnostics Market Is Advancing with AI and Biomarker-Based Screening?Executive Summary Prostate Cancer Diagnostics Market: Growth Trends and Share Breakdown CAGR Value The global prostate cancer diagnostics market size was valued at USD 4.63 billion in 2024 and is expected to reach USD 10.31 billion by 2032, at a CAGR of 10.50% during the forecast period Prostate Cancer Diagnostics Market research report is a verified source of data and information that...0 Comentários 0 Compartilhamentos 8KB Visualizações 0 Anterior
Páginas impulsionada
© 2026 Myliveroom — Live Events & Online Communities
Portuguese (Brazil)